Non-Current Liabilities
Hedged Liability - Fair Value Hedge
Pfizer Hedged Liability - Fair Value Hedge increased by 7.7% to -$156.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 550.0%, from -$24.00M to -$156.00M.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
First reportedQ4 2024
Last reportedQ3 2025
Metric ID:
hedged_liability_fair_value_hedgeHistorical Data
8 periods
| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|
| Value | -$131.00M | -$320.00M | -$355.00M | -$24.00M | -$384.00M | -$242.00M | -$169.00M | -$156.00M |
| QoQ Change | — | -144.3% | -10.9% | +93.2% | <-999% | +37.0% | +30.2% | +7.7% |
| YoY Change | — | — | — | — | -193.1% | +24.4% | +52.4% | -550.0% |
Range-$384.00M – -$24.00M
CAGR+10.5%
Avg YoY Growth-166.6%
Median YoY Growth-84.4%
Current Streak3 quarters growth
Hedged Liability - Fair Value Hedge at Other Companies
Frequently Asked Questions
- What is Pfizer's hedged liability - fair value hedge?
- Pfizer (PFE) reported hedged liability - fair value hedge of -$156.00M in Q3 2025.
- How has Pfizer's hedged liability - fair value hedge changed year-over-year?
- Pfizer's hedged liability - fair value hedge decreased by 550.0% year-over-year, from -$24.00M to -$156.00M.